Enterprise readiness · Adoption spend
Zifo survey finds biopharma agentic AI adoption limited
Zifo’s global survey found rising biopharma interest in agentic AI while practical adoption remains low and ROI and lab orchestration remain key concerns.
Read the original at prnewswire.comOpens the publisher's site in a new tab